| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/23/2002 | US20020061307 Polyalkylene oxide-modified single chain polypeptides |
| 05/23/2002 | US20020061306 DNA sequences encoding proteins having ability to bind alpha 2-macroglobulin; expression vectors; immunology |
| 05/23/2002 | US20020061297 Novel recombinant DNA vectors for gene therapy |
| 05/23/2002 | US20020061296 Nond-denatured apoptin (with fusion protein or tag) as anticancer, anti-autoimmune disease therapeutic proteins (HIV TAT proteins) |
| 05/23/2002 | US20020061295 Myocardial grafts and cellular compositions useful for same |
| 05/23/2002 | DE10152660A1 Identifying neuronal stem cells, useful e.g. for transplantation to regenerate nerves, using a sequence that encodes intracellular hyaluronic acid-binding protein |
| 05/23/2002 | DE10126367A1 Pharmaceutical composition comprises Borrelia antigens and encoding nucleic acid, useful for diagnosis, treatment and prevention of Lyme borreliosis |
| 05/23/2002 | DE10057801A1 New polynucleotide encoding the CysQ transporter of coryneform bacteria, useful, when over expressed, for increasing fermentative production of amino acids |
| 05/23/2002 | CA2771909A1 Proteins producing an altered immunogenic response and methods of making and using the same |
| 05/23/2002 | CA2749307A1 Promoter sequence of a gene encoding an exoenzyme toxin of aeromonas salmonicida, and uses therefor |
| 05/23/2002 | CA2707684A1 Novel exoenzyme toxin of aeromonas salmonicida, and uses therefor |
| 05/23/2002 | CA2632696A1 Modified clostridial neurotoxins with altered biological persistence |
| 05/23/2002 | CA2467360A1 Exoenzyme toxin of aeromonas salmonicida, and uses therefor |
| 05/23/2002 | CA2467309A1 Type iii secretion pathway in aeromonas salmonicida, and uses therefor |
| 05/23/2002 | CA2429897A1 M. tuberculosis chaperonin 10 and uses thereof |
| 05/23/2002 | CA2429894A1 M. tuberculosis chaperonin 60.1 and uses thereof |
| 05/23/2002 | CA2429515A1 Retinoid pathway assays, and compositions therefrom |
| 05/23/2002 | CA2429460A1 Artery smooth muscle- and vein smooth muscle-specific proteins and uses therefor |
| 05/23/2002 | CA2429455A1 Fat regulated genes, uses thereof, and compounds for modulating same |
| 05/23/2002 | CA2429342A1 Promoters exhibiting endothelial cell specificity and methods of using same |
| 05/23/2002 | CA2429317A1 Specific promoter of the human vascular endothelial cadherin-2 (hve-cad-2) gene and the therapeutic uses thereof |
| 05/23/2002 | CA2429214A1 Guanosine triphosphate (gtp)-binding protein-coupled receptor protein, bg37 |
| 05/23/2002 | CA2429195A1 Immunoglobulin superfamily proteins |
| 05/23/2002 | CA2429144A1 Periplasmic domain of an enterobacterium omp protein and its use as carrier or adjuvant |
| 05/23/2002 | CA2429142A1 Maize yellow stripe1 and related genes |
| 05/23/2002 | CA2429140A1 Antibody against norwalk virus and method of detecting virus by using the antibody |
| 05/23/2002 | CA2428754A1 Corticotropin releasing factor receptor 2 deficient mice and uses thereof |
| 05/23/2002 | CA2428716A1 Method to identify genes associated with chronic myelogenous leukemia |
| 05/23/2002 | CA2428350A1 Slo2 and slo4, novel potassium channel proteins from human brain |
| 05/23/2002 | CA2428136A1 Modified clostridial neurotoxins with altered biological persistence |
| 05/23/2002 | CA2427902A1 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 05/23/2002 | CA2427896A1 Carrier vectors through an epithelium with tight junctions |
| 05/23/2002 | CA2427207A1 Multipurpose packages for sterilised products or products to be sterilised |
| 05/23/2002 | CA2427010A1 Transporters and ion channels |
| 05/22/2002 | EP1207203A2 DNA sequence and papillomavirus vaccine |
| 05/22/2002 | EP1207202A1 Nucleic acid molecules encoding a protein interacting with the chemokine receptor CCR5 or other chemokine receptor family members |
| 05/22/2002 | EP1207201A1 Novel g protein-coupled receptor protein and dna thereof |
| 05/22/2002 | EP1207200A1 High affinity choline transporter |
| 05/22/2002 | EP1207198A1 Novel g protein-coupled receptor protein and dna thereof |
| 05/22/2002 | EP1207196A1 Immortalized preosteoblasts and method for their production |
| 05/22/2002 | EP1207169A1 Novel g protein-coupled receptor protein and dna thereof |
| 05/22/2002 | EP1207168A1 Polypeptides and nucleic acids encoding the same |
| 05/22/2002 | EP1206701A1 Antigenic components of selected indicator fungi and their use in methods and test kits |
| 05/22/2002 | EP1206582A1 Methods and compositions for inhibition of membrane fusion-associated events, including hiv transmission |
| 05/22/2002 | EP1206578A2 Bdnf polymorphism and association with bipolar disorder |
| 05/22/2002 | EP1206577A2 Binary encoded sequence tags |
| 05/22/2002 | EP1206573A1 26 human secreted proteins |
| 05/22/2002 | EP1206563A1 Genetically altered dendritic cells transduced with adeno-associated virus (aav), methods of producing said cells and uses thereof |
| 05/22/2002 | EP1206561A2 Method for production of proteinaceous substances |
| 05/22/2002 | EP1206558A2 Plants with modified polyunsaturated fatty acids |
| 05/22/2002 | EP1206557A2 Plant defensin variants |
| 05/22/2002 | EP1206554A1 Activatable recombinant neurotoxins |
| 05/22/2002 | EP1206550A1 Proteins derived from white spot syndrome virus and uses thereof |
| 05/22/2002 | EP1206549A1 Basb119 polypeptide and polynucleotide from moraxella catarrhalis |
| 05/22/2002 | EP1206548A1 Basb118 polypeptide and polynucleotide from moraxella catarrhalis |
| 05/22/2002 | EP1206547A2 Moraxella catarrhalis antigen basb117 |
| 05/22/2002 | EP1206546A2 Moraxella catarrhalis antigen basb120 |
| 05/22/2002 | EP1206545A1 Basb116 dna and proteins from moraxella catarrhalis |
| 05/22/2002 | EP1206544A2 Odorant-binding human proteins fixing hydrophobic ligands: polypeptides and polynucleotides coding for said polypeptides and uses thereof |
| 05/22/2002 | EP1206543A2 Membrane associated proteins |
| 05/22/2002 | EP1206542A2 Replication protein a binding transcriptional factor (rbt1) and uses thereof |
| 05/22/2002 | EP1206541A1 Dendritic enriched secreted lymphocyte activation molecule |
| 05/22/2002 | EP1206540A2 Dna sequences isolated from human colonic epithelial cells |
| 05/22/2002 | EP1206539A2 Medicament for the prevention and/or the treatment of ischemic heart and peripheral vascular diseases, tumour and wounds |
| 05/22/2002 | EP1206538A1 Constitutively active stat proteins and their uses for identifying modulators of activity including dysproliferative cellular changes |
| 05/22/2002 | EP1206537A2 Nucleic acids and polypeptides of invertebrate twik channels and methods of use |
| 05/22/2002 | EP1206536A2 HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS |
| 05/22/2002 | EP1206535A1 Tumor-associated antigen (r11) |
| 05/22/2002 | EP1206534A1 Prostate cancer-related gene 3 (pg3) and biallelic markers thereof |
| 05/22/2002 | EP1206533A1 Novel response element |
| 05/22/2002 | EP1206495A1 Chimeric polypeptides, method for production and uses thereof |
| 05/22/2002 | EP1206492A2 Self-aligning peptides derived from human elastin and other fibrous proteins |
| 05/22/2002 | EP1206491A1 Tgf-beta receptor polynucleotides, polypeptides, and antibodies |
| 05/22/2002 | EP1206490A1 Vegf-d and angiogenic use thereof |
| 05/22/2002 | EP1206489A2 Orally active peptides that prevent cell damage and death |
| 05/22/2002 | EP1206488A2 Method for isolating and purifying grass pollen allergens |
| 05/22/2002 | EP1206487A2 Notch receptor ligands and uses thereof |
| 05/22/2002 | EP1206482A2 Method for coupling, in solution, a peptide with at least another compound and uses thereof |
| 05/22/2002 | EP1206479A1 A polynucleotide encoding a human junctional adhesion protein (jam-2) |
| 05/22/2002 | EP1206477A1 Cloning of the streptomyces avermitilis genes for glycosylation of avermectin aglycones |
| 05/22/2002 | EP1206278A2 Peptide mixture and vaccine against a chronic viral infection |
| 05/22/2002 | EP1206273A2 Peptides that block viral infectivity and methods of use thereof |
| 05/22/2002 | EP1206272A1 Hybrid polypeptides with enhanced pharmacokinetic properties |
| 05/22/2002 | EP1206251A1 Amplification of folate-mediated targeting to tumor cells using nanoparticles |
| 05/22/2002 | EP1123004B1 Utilization of an antifungal protein from streptomyces tendae against plant pathogenic fungi |
| 05/22/2002 | EP0929564A4 High level expression of proteins |
| 05/22/2002 | EP0726947B1 Insecticidal toxins derived from funnel web (atrax or hadronyche) spiders |
| 05/22/2002 | EP0720623B1 Monoclonal antibodies against leukocyte-specific g-protein-coupled receptors |
| 05/22/2002 | EP0665754B1 Antimicrobial peptides |
| 05/22/2002 | EP0452364B1 Method for preparing water soluble polypeptides |
| 05/22/2002 | CN1350591A One step sample preparation and detection of nucleic acids in complex biological samples |
| 05/22/2002 | CN1350587A Acquired resistance genes in plants |
| 05/22/2002 | CN1350585A i(Neisseria meningitidis) polypeptide BASBO52 |
| 05/22/2002 | CN1350584A Process for producing recombinant insulain from novel fused protein |
| 05/22/2002 | CN1350583A Recombinant platelet collagen receptor Glycoprotein VI and its pharmaceutical use |
| 05/22/2002 | CN1350582A Method for generating split, non-transferable genes that are able to express an active protein product |
| 05/22/2002 | CN1350578A Recombinant influenza viruses for vaccines and gene therapy |
| 05/22/2002 | CN1350549A Compositions and methods for generating monoclonal antibodies representative of a specific cell type |
| 05/22/2002 | CN1350548A Long lasting insulinotropic peptides |
| 05/22/2002 | CN1350547A Alleviation of the alelrgenic potential of airborne and contact allergens by thioredoxin |